Dynavax Technologies Corporation (LON:0IDA)
London · Delayed Price · Currency is GBP · Price in USD 10.39
+0.49 (4.94%)
At close: Aug 11, 2025
G1 Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -52.73 | 27.31 | -6.39 | 293.16 | 76.71 | -75.24 | Upgrade |
Depreciation & Amortization | 8.2 | 8.05 | 7.28 | 6.67 | 7.06 | 9.34 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | -1 | -1 | -1 | -6.95 | Upgrade |
Loss (Gain) From Sale of Investments | -9.92 | -14.55 | -16.56 | -4.18 | 0.47 | 0.48 | Upgrade |
Stock-Based Compensation | 53.52 | 52.62 | 42.59 | 32.92 | 21.29 | 13.48 | Upgrade |
Provision & Write-off of Bad Debts | 10.97 | - | 12.31 | - | - | - | Upgrade |
Other Operating Activities | 91.92 | 9.11 | 1.12 | 33.58 | 58.78 | -0.45 | Upgrade |
Change in Accounts Receivable | -10.72 | -2.37 | 43.27 | -15.7 | -109.16 | -13.78 | Upgrade |
Change in Inventory | -19.08 | -19.91 | 3.91 | -32.4 | -0.23 | -22.36 | Upgrade |
Change in Accounts Payable | -2.04 | 3.9 | 1.95 | 0.69 | -0.77 | -3.45 | Upgrade |
Change in Unearned Revenue | - | - | - | -349.86 | 311.65 | 38.21 | Upgrade |
Change in Other Net Operating Assets | 6.15 | 2.35 | 12.08 | 98.85 | -29.28 | -31.55 | Upgrade |
Operating Cash Flow | 76.27 | 66.51 | 100.56 | 62.72 | 335.53 | -92.25 | Upgrade |
Operating Cash Flow Growth | 95.92% | -33.86% | 60.35% | -81.31% | - | - | Upgrade |
Capital Expenditures | -10.2 | -6.35 | -4.1 | -7.14 | -9.48 | -4.07 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 1 | 1 | 1 | 6.85 | Upgrade |
Sale (Purchase) of Intangibles | - | - | - | - | - | -7 | Upgrade |
Investment in Securities | 119.81 | -11.68 | -150.82 | -309.86 | 22.7 | -22.31 | Upgrade |
Investing Cash Flow | 109.6 | -18.04 | -153.93 | -316 | 14.23 | -26.53 | Upgrade |
Long-Term Debt Issued | - | - | - | - | 219.82 | - | Upgrade |
Long-Term Debt Repaid | - | - | - | - | -190.19 | - | Upgrade |
Net Debt Issued (Repaid) | 39.71 | - | - | - | 29.63 | - | Upgrade |
Issuance of Common Stock | 11.9 | 7.29 | 7.9 | 19.53 | 53.39 | 109.5 | Upgrade |
Repurchase of Common Stock | -212.93 | -109.31 | -6.51 | - | - | - | Upgrade |
Other Financing Activities | -38.88 | - | - | - | -27.24 | - | Upgrade |
Financing Cash Flow | -200.2 | -102.02 | 1.39 | 19.53 | 55.78 | 109.5 | Upgrade |
Foreign Exchange Rate Adjustments | 0.96 | -0.86 | 0.32 | -0.44 | -1.43 | 1.49 | Upgrade |
Net Cash Flow | -13.37 | -54.4 | -51.66 | -234.2 | 404.1 | -7.79 | Upgrade |
Free Cash Flow | 66.07 | 60.16 | 96.46 | 55.58 | 326.05 | -96.32 | Upgrade |
Free Cash Flow Growth | 86.99% | -37.63% | 73.56% | -82.95% | - | - | Upgrade |
Free Cash Flow Margin | 20.89% | 21.70% | 41.53% | 7.69% | 74.20% | -239.31% | Upgrade |
Free Cash Flow Per Share | 0.53 | 0.45 | 0.75 | 0.37 | 2.45 | -0.95 | Upgrade |
Cash Interest Paid | 4.84 | 5.64 | 5.64 | 5.64 | 9.82 | 16.54 | Upgrade |
Cash Income Tax Paid | 3.77 | 4.59 | 2.01 | 2.21 | 1.31 | - | Upgrade |
Levered Free Cash Flow | 43.09 | 49.1 | 109.54 | -63.79 | 276.19 | -91.81 | Upgrade |
Unlevered Free Cash Flow | 47.3 | 53.35 | 113.76 | -59.58 | 283.18 | -79.89 | Upgrade |
Change in Working Capital | -25.69 | -16.04 | 61.21 | -298.42 | 172.22 | -32.91 | Upgrade |
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.